Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome

被引：31

作者：

Kalogiannidis, Loannis ^{[1
]}

Lambrechts, Sandrijne ^{[1
]}

Amant, Frederic ^{[1
]}

Neven, Patrick ^{[1
]}

Van Gorp, Toon ^{[1
]}

Vergote, Ignace ^{[1
]}

机构：

[1] Katholieke Univ Leuven Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, B-3000 Louvain, Belgium

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2007年 / 196卷 / 03期

关键词：

endometrial cancer; laparoscopy; laparotomy; lymphadenectomy;

D O I：

10.1016/j.ajog.2006.10.870

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Objective: To determine the feasibility of laparoscopic-assisted vaginal hysterectomy (LAVH) in the treatment of clinical FIGO stage I endometrial adenocarcinoma and long-term survival outcome. Study design: Prospective cohort study without randomization of 169 consecutive patients. Laparoscopy or laparotomy was selected based on size and mobility of the uterus and Body Mass Index (BMI). Lymphadenectomy was only performed in cases at high-risk for nodal metastases. Results: Sixty-nine patients (41%) treated successfully by LAVH (LAVH group) while 100 (59%) by total abdominal hysterectomy (TAH) (laparotomy group). Four out of 73 patients initially approached by laparoscopy were converted to laparotomy (5.5%). Lymphadenectomy was performed in 40% of the LAVH and 57% of TAH group (P = 0.03). The median number of pelvic lymph nodes removed by LAVH and laparotomy was 15 (range 2-31) and 21 (range 2-65), respectively (P = 0.05). LAVH was associated with more surgical FIGO stage IA disease and a smaller tumor diameter. Operative time was significantly longer with laparoscopy compared with laparotomy, while blood loss and duration of hospitalization was significantly lower in the LAVH group. The recurrence rate in the LAVH group was 8.7%, compared with 16% in the laparotomy group (not significant, NS). The actuarial overall survival (OS) and disease-free survival (DFS) for the LAVH were 93% and 91% compared with 86% and 84% in the TAH, respectively (NS). In the multivariate analyses histological subtype was the only independent prognostic factor for DFS, while surgical technique was not. Conclusion: LAVH with lymphadenectomy in selected population in high-risk patients with clinical stage I endometrial adenocarcinoma and with favorable body mass index of less than 35kg/m2, appears to be safe procedure. © 2007 Mosby, Inc. All rights reserved.

引用

页码：248 / 250

页数：3

共 44 条

[21]

Scribner D.R., Walker J.L., Johnson G.A., McMeekin S.D., Gold M.A., Mannel R.S., Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible?, Gynecol Oncol, 83, pp. 563-568, (2001)

[22]

Scribner D.R., Mannel R.S., Walker J.L., Johnson G.A., Cost analysis of laparoscopy versus laparotomy for early endometrial cancer, Gynecol Oncol, 75, pp. 460-463, (1999)

[23]

Spirtos N.M., Schlaerth J.B., Gross G.M., Spirtos T.W., Schlaerth A.C., Ballon S.C., Cost and quality-of-life analyses for early endometrial cancer: laparotomy versus laparoscopy, Am J Obstet Gynecol, 174, pp. 1795-1800, (1996)

[24]

Zullo F., Palomba S., Russo T., Falbo A., Costantino M., Tolino A., Et al., A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life, Am J Obstet Gynecol, 193, pp. 1344-1352, (2005)

[25]

Zapico A., Fuentes P., Grassa A., Armanz F., Otazua J., Cortes-Prieto J., Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in stages I and II endometrial cancer. Operating data, follow up and survival, Gynecol Oncol, 98, pp. 222-227, (2005)

[26]

Eltabbakh G.H., Analysis of survival after laparoscopy in women with endometrial cancer, Cancer, 95, (2002)

[27]

Magrina J.F., Mutone N.F., Weaver A.L., Magtibay P.M., Fowler R.S., Cornella J.L., Laparoscopic lymphadenectomy and vaginal or laparoscopic hysterectomy with bilateral salpingo-oophorectomy for endometrial cancer: morbidity and survival, Am J Obstet Gynecol, 181, pp. 376-381, (1999)

[28]

Annual reports on the results of treatment in gynecologic cancer, Int J Gynaecol Obstet, 28, pp. 189-193, (1989)

[29]

New classification of physical status, Anesthesiology, 24, (1963)

[30]

Chassagne D., Sismondi P., Horiot J.C., Sinistero G., Bey P., Zola P., Et al., A glossary for reporting complications of treatment in gynaecological cancers, Radiother Oncol, 26, pp. 183-202, (1993)

← 1 2 3 4 5 →